ARMP
Armata Pharmaceuticals Inc
3.50$
+6.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -790.8% | -530.5% | -1,095.7% | – | -298.1% | -641.9% | -1,543.8% | -332.5% | -370.8% | -615.1% | -732.8% | -345.3% | -458.6% | |
| 18.0% | 19.2% | 32.8% | – | 10.5% | 30.8% | 76.8% | 16.9% | 31.9% | 38.5% | 57.9% | 64.5% | 51.7% | |
| -30.4% | 12.6% | 55.3% | – | 22.5% | 28.7% | 159.1% | 26.5% | 53.7% | 58.2% | 136.2% | 135.1% | 103.2% | |
| 7.5% | 36.5% | -175.2% | – | -31.4% | 96.3% | -243.8% | -92.0% | 156.5% | -3.0% | 113.9% | -115.9% | -4.1% | |
| 286.7% | 157.1% | 25.9% | – | 11.4% | 6.2% | 20.2% | 6.9% | 20.9% | 4.8% | 8.0% | 0.7% | 6.7% | |
| -286.7% | -156.4% | -25.9% | – | -11.4% | 6.2% | -20.2% | -6.9% | -20.9% | -4.8% | -8.0% | -0.7% | -6.7% | |
| – | -2.8% | – | – | -2.1% | – | -2.9% | – | -2.8% | -1.3% | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | 2,036.7% | 0.0% | 1,294.2% | 0.0% | 0.0% | – | – | |
| 2,024.9% | -2.8% | 3,616.0% | – | -2.1% | 0.0% | 2,033.8% | 0.0% | 1,291.5% | 60.6% | 81.2% | 1,110.8% | 796.5% | |
| 947.4% | -689.7% | 2,519.4% | – | -311.6% | -635.6% | 469.9% | -339.3% | 899.7% | -559.3% | -659.6% | 764.9% | 331.1% | |
| -1,077.5% | -687.6% | -1,121.5% | – | -309.6% | -635.6% | -1,564.0% | -339.3% | -391.7% | -619.9% | -740.8% | -345.9% | -465.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.